Recent advances in the treatment of achalasia

Gastrointestinal Endoscopy Clinics of North America

Volumn 7, Issue 2, 1997, Pages 191-206

  Pasricha, P J ^a   Kalloo, A N ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; ISOSORBIDE DINITRATE;

BALLOON DILATATION; ESOPHAGUS ACHALASIA; ESOPHAGUS MYOTOMY; GASTROINTESTINAL ENDOSCOPY; HUMAN; LASER SURGERY; LOWER ESOPHAGUS SPHINCTER; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SPHINCTER;

EID: 0030973897     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1052-5157(18)30307-6     Document Type: Review

References (62)

1. Aggestrup S. Uddman R. Sundler F. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia Gastroenterology 84 1983 924 927
2. Albanese A. Bentivoglio A.R. Cassetta E. Review article: The use of botulinum toxin in the alimentary tract Aliment Pharmacol Ther 9 1995 599 604
3. Ancona E. Peracchia A. Zaninotto G. Heller laparoscopic cardiomyotomy with antireflux anterior fundoplication (Dor) in the treatment of esophageal achalasia Surg Endosc 7 1993 459 461
4. Andreollo N.A. Earlam R.J. Heller’s myotomy for achalasia: Is an added anti-reflux procedure necessary? Br J Surg 74 1987 765 769
5. Annesse V. Perri F. Napolitano G. Botulinum toxin for achalasia: A placebo controlled trial with follow-up of six months Gastroenterology 108 1995 A563
6. Bansal R. Koshy S. Schieman J.M. Interim analysis of a randomized trial of Witzel pneumatic dilation vs intrasphincteric injection of botulinum toxin (BOTOX) for achalasia Gastroenterology 110 1996 A56
7. Blasi J. Chapman E.R. Link E. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 Nature 365 1993 238 241
8. Boyce H.W. Robinson B.E. Jones J. Botulinum toxin A (Botox) therapy for classic and variant achalasia Gastrointest Endosc 43 1996 292 [abstract]
9. Cassella R.R. Brown A.L.J. Sayre G.P. Achalasia of the esophagus: Pathologic and etiologic considerations Ann Surg 160 1964 574
10. Castell D.O. Katzka D.A. Botulinum toxin for achalasia: To be or not to be? Gastroenterology 110 1996 1650 1652
11. Cuilliere C. Ducrotte P. Zerbib F. Achalasia: Outcome of patients treated by intrasphincteric injection of botulinum toxin Gastroenterology 110 1996 A86
12. de Paiva A. Ashton A.C. Foran P. Botulinum toxin A like type B and tetanus toxins fulfills criteria for being a zinc-dependent protease J Neurochem 238 1993 238 241
13. Eaker E.Y. Gordon M.D. Esophageal botulinum toxin injection in high risk achalasia patients: A prospective trial Gastroenterology 110 1996 A99
14. Eckardt V.F. Aignherr C. Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation Gastroenterology 103 1992 1732 1738
15. Ellis F.H. Jr. Watkins E. Jr. Gibb S.P. Ten to 20-year clinical results after short esophagomyotomy without an antireflux procedure (modified Heller operation) for esophageal achalasia Eur J Cardiothorac Surg 6 1992 86 89
16. Fiorini A.B. Corti R. Valero J.L. Botulinum toxin for achalasia: Results of a controlled trial with a follow-up of twelve months Gastrointest Endosc 43 1996 335
17. Gaudric M. Guimbaud R. Chaussade S. Pneumatic dilation (PD) versus intrasphincteric botulinum toxin (BT) in the treatment of achalasia: Preliminary results of a controlled study Gastroenterology 110 1996 A667
18. Gelfond M. Rozen P. Gilat T. Isosorbide dinitrate and nifedipine treatment of achalasia: A clinical, manometric and radionuclide evaluation Gastroenterology 83 1982 963 969
19. Gelfond M. Rozen P. Keren S. Effect of nitrates on LOS pressure in achalasia: A potential therapeutic aid Gut 22 1981 312 318
20. Goldblum J.R. Whyte R.I. Orringer M.B. Achalasia: A morphologic study of 42 resected specimens Am J Surg Pathol 18 1994 327 337
21. Guelrud M. Rossiter A. Souney P.F. The effect of vasoactive intestinal polypeptide on the lower esophageal sphincter in achalasia Gastroenterology 103 1992 377 382
22. Guelrud M. Rossiter A. Souney P.F. Transcutaneous electrical nerve stimulation decreases lower esophageal sphincter pressure in patients with achalasia Dig Dis Sei 36 1991 1029 1033
23. Hills C, Schiano T, Parkman HP, et al: Botulinum toxin improves symptoms in idiopathic, but not secondary achalasia [abstract]. Am J Gastroenterol 1995
24. Hoffman B.J. Knapple W. Bhutani M.S. EUS-guided injection of botulinum toxin for achalasia Gastrointest Endosc 43 1996 533 [abstract]
25. Jaakkola A. Reinikainen P. Ovaska J. Barrett’s esophagus after cardiomyotomy for esophageal achalasia Am J Gastroenterol 89 1994 165 169
26. Jankovic J. Brin M.F. Therapeutic uses of botulinum toxin N Engl J Med 324 1991 1186 1194
27. Jankovic J. Schwartz K.S. Clinical correlates of response to botulinum toxin injections Arch Neurol 48 1991 1253 1256
28. Jin H. Potter G.D. Shah A.N. Effect of intrasphincteric injection of botulinum toxin on esophageal motility in achalasia Gastroenterology 108 1995 A123
29. Kim C.H. Cameron A.J. Hsu J.J. Achalasia: Prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation Mayo Clin Proc 68 1993 1067 1073
30. Kotfila R. Camp R. Willits N. Transendoscopic injection of botulinum toxin should be the initial therapy for achalasia Gastrointest Endosc 43 1996 298
31. Kozarek R.A. Gelfand M.D. Patterson D.J. Prospective trial of 50 vs 100 IU of type A botulinum toxin for idiopathic achalasia Gastroenterology 110 1996 A162
32. Liebermann-Meffert D. Allgower M. Schmid P. Muscular equivalent of the lower esophageal sphincter Gastroenterology 76 1979 31
33. Malthaner R.A. Todd T.R. Miller L. Long-term results in surgically managed esophageal achalasia Ann Thorac Surg 58 1994 1343 1346
34. Mearin F. Mourelle M. Guamer F. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction Eur J Clin Invest 23 1993 724 728
35. Mearin F. Zacchi P. Armengol J.R. Effect of transcutaneous nerve stimulation on esophageal motility in patients with achalasia and scleroderma Scand J Gastroenterol 25 1990 1018 1023
36. Moreto M, Ojembarrena E, Rodriguez M-L: Endoscopic injection of the ethanolamine as an effective treatment for achalasia: A first report. Endoscopy 1996, in press
37. Ortega J.A. Madureri V. Perez L. Endoscopic myotomy in the treatment of achalasia Gastrointest Endosc 26 1980 8 10
38. Parkman H.P. Reynolds J.C. Ouyang A. Pneumatic dilatation of esophagomyotomy treatment for idiopathic achalasia: Clinical outcomes and cost analysis Dig Dis Sei 38 1993 75 85
39. Pasricha PJ: Achalasia: Are we winning the war or losing the peace? Endoscopy 1996, In press
40. Pasricha P.J. Kalloo A.N. Botulinum toxin for the treatment of gastrointestinal smooth muscle disorders Jankovic J. Hallet M. Therapy with Botulinum Toxin 1994 Marcel Dekker New York
41. Pasricha P.J. Ravich W.J. Kalloo A.N. Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets Gastroenterology 105 1993 1045 1049
42. Pasricha P.J. Rai R. Ravich W.J. Botulinum toxin for achalasia: Long-term followup and predictors of outcome Gastroenterology 110 1996 1410 1415
43. Pasricha P.J. Ravich W.J. Hendrix T.R. Intrasphincteric botulinum toxin for the treatment of achalasia N Engl J Med 332 1995 774 778
44. Pasricha P.J. Ravich W.J. Hendrix T.R. Treatment of achalasia with intrasphincteric injection of botulinum toxin: A pilot trial Ann Intern Med 121 1994 590 591
45. Patti M.G. Pellegrini C.A. Minimally invasive approaches to achalasia Semin Gastrointest Dis 5 1994 108 112
46. Pellegrini C. Wetter L.A. Patti M. Thoracoscopic esophagomyotomy: Initial experience with a new approach for the treatment of achalasia Ann Surg 216 1992 291 296
47. Pellegrini C.A. Leichter R. Patti M. Thoracoscopic esophageal myotomy in the treatment of achalasia Ann Thorac Surg 56 1993 680 682
48. Reynolds J.C. Parkman H.P. Achalasia Gastroenterol Clin North Am 18 1989 223 255
49. Richter J.E. Motility disorders of the esophagus Yamada T. Textbook of Gastroenterology 1995 JB Lippincott Philadelphia 1174
50. Rollan A. Gonzalez R. Carvajal S. Endoscopic intrasphincteric botulinum toxin injection for the treatment of achalasia J Clin Gastroenterol 20 1995 189 191
51. Rosati R. Fumagalli U. Bonavina L. Laparoscopic approach to esophageal achalasia Am J Surg 169 1995 424 427
52. Sanderson D.R. Ellis F.H. Jr. Olsen A.M. Achalasia of the esophagus: Results of therapy by dilation, 1950–1967 Chest 58 1970 116 121
53. Schroeder P. Slaughter R. Torbey C. Treatment of achalasia: Botulinum toxin vs pneumatic dilation Am J Gastroenterol 90 1995 1571
54. Scott A.B. Clostridial toxins as therapeutic agents Simpson L.L. Botulinum neurotoxin and tetanus toxin 1989 Academic Press San Diego 399
55. Simpson L.L. The origin, structure, and pharmacological activity of botulinum toxin Pharmacol Rev 33 1981 155 188
56. Singaram C. Sweet M.A. Belcaster G. Detection of a novel antineuronal autoantibody in patients with achalasia Gastroenterology 106 1994 A566
57. Stein H.J. Korn O. Liebermann-Meffert D. Manometric vector volume analysis to assess lower esophageal sphincter function Ann Chir Gynaecol 84 1995 151 158
58. Swanstrom L.L. Pennings J. Laparoscopic esophagomyotomy for achalasia Surg Endosc 9 1995 286 292
59. Traube M. Dubovik S. Lange R.C. The role of nifedipine therapy in achalasia: Results of a randomized, double-blind, placebo-controlled study Am J Gastroenterol 84 1989 1259 1262
60. Traube M. Hongo M. Magyar L. Effects of nifedipine in achalasia and in patients with high-amplitude peristaltic esophageal contractions JAMA 252 1984 1733 1736
61. Triadafilopoulos G. Aaronson M. Sackei S. medical treatment of esophageal achalasia: Double-blind crossover study with oral nifedipine, verapamil, and placebo Dig Dis Sei 36 1991 260 267
62. Vantrappen G. Hellemans J. Deloff W. Treatment of achalasia with pneumatic dilatations Gut 1 1971 268 275